Showing results (1101-1110 of 1,255) with videos related to
Sort By:
Pageof 126
Cancer Treatment and Research Communications|August 1, 2021
Clinical epidemiology of gallbladder cancer in North-Central India and association of immunological markers, NLR, MLR and PLR in the diagnostic/prognostic prediction of GBCJyotsna Singh, Durgesh Shukla, Sanjiv Gupta, et al.Cancer Treatment and Research Communications|January 30, 2023
Real-world treatment outcomes in HR+ HER2- metastatic breast cancer patients treated with CDK4/6 inhibitors: Results from a reference center in BrazilMarcello Moro Queiroz, Karina Perez Sacardo, Mauricio Fernando Ribeiro, et al.Cancer Treatment and Research Communications|January 30, 2023
The predictive value of YAP-1 and POU2F3 for the efficacy of immuno-chemotherapy in extensive-stage SCLC patientsYu-Qing Chen, Ling-Ling Gao, Ling-Cong Kong, et al.Cancer Treatment and Research Communications|August 14, 2022
Reassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapyTobiloba C Elebiyo, Damilare Rotimi, Ikponmwosa O Evbuomwan, et al.Cancer Treatment and Research Communications|February 24, 2023
The incidence of colorectal cancer (CRC) in Georgia continues to increase: A population-based registry studyMiranda Nonikashvili, Maia Kereselidze, Otar Toidze, et al.Cancer Treatment and Research Communications|September 4, 2021
Sensitive cell-free tumor DNA analysis in supernatant pleural effusions supports therapy selection and disease monitoring of lung cancer patientsRemco de Kock, Chantal Knoops, Mieke Baselmans, et al.Cancer Treatment and Research Communications|March 13, 2023
Real-world palbociclib effectiveness in patients with metastatic breast cancer: Focus on neutropenia-related treatment modification strategies and clinical outcomesMariska Q N Hackert, Cornelia F van Uden-Kraan, Mariette J Agterof, et al.Cancer Treatment and Research Communications|February 26, 2025
Factors influencing smoking cessation in Lebanese patients with bladder cancer: A cross sectional studyGeorges Horkoss, Joey El Khoury, Rami Halabi, et al.Cancer Treatment and Research Communications|November 13, 2024
Efficacy of subsequent treatment for unresectable locally-advanced non-small cell lung cancer after relapse of concurrent chemoradiotherapy with durvalumab consolidation therapy: A single-center retrospective studyYuichiro Nishibori, Hirotsugu Kenmotsu, Kenju Ando, et al.Cancer Treatment and Research Communications|November 4, 2024
Clinical research progress of targeted therapy combined with immunotherapy for advanced cholangiocarcinomaQin Liu, Yuanyuan Chen, Yan Hu, et al.Pageof 126